Merrimack Pharmaceuticals Inc: DEFA14A filed Apr 30, 2024

Form type

DEFA14A

Filing date

Apr 30, 2024

Accession number

0001193125-24-125372

Filer

Merrimack Pharmaceuticals Inc (CIK 1274792)